Dextrose and Electrolyte No. 48
Active substance: DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, SODIUM CHLORIDE
INJECTION · DEXTROSE MONOHYDRATE 5 g/100mL, SODIUM LACTATE 260 mg/100mL, POTASSIUM CHLORIDE 141 mg/100mL, MAGNESIUM CHLORIDE 31 mg/100mL, POTASSIUM PHOSPHATE, MONOBASIC 20 mg/100mL, SODIUM CHLORIDE 12 mg/100mL
United StatesActive
Marketing holder: Baxter Healthcare Company
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DEXTROSE MONOHYDRATE · 5 g/100mL
- SODIUM LACTATE · 260 mg/100mL
- POTASSIUM CHLORIDE · 141 mg/100mL
- MAGNESIUM CHLORIDE · 31 mg/100mL
- POTASSIUM PHOSPHATE, MONOBASIC · 20 mg/100mL
- SODIUM CHLORIDE · 12 mg/100mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-9679-7c24-8bd3-1eaefa7ef2a9,01a1208c-9895-793e-9111-6709a1287329,01a1208c-bb5f-7e6a-a861-e4d043b92cb2,01a1208c-f5bf-70a6-b465-0c472c890815,01a1208c-f5d0-70f2-bfba-af72915ceeb8;count=73 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0338-0143
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0338-0143 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0338-0143 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0338-0143 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0338-0143 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 0338-0143 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 0338-0143 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 0338-0143 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 0338-0143 · Verified 2026-10-09 · open in source